Feasibility, efficacy, and adverse effects of outpatient antibacterial prophylaxis in children with acute myeloid leukemia

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|120|13|1985-1992

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.13, 2014-07, pp. : 1985-1992

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

AAML0523: A report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent acute myeloid leukemia

By  

CANCER, Vol. 120, Iss. 16, 2014-08 ,pp. : 2482-2489

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dose, schedule, safety, and efficacy of guadecitabine in relapsed or refractory acute myeloid leukemia

By  

CANCER, Vol. 124, Iss. 2, 2018-01 ,pp. : 325-334

John Wiley & Sons Inc

Access to resources Recommend Favorite

Gemtuzumab Ozogamicin (Mylotarg®) in Children with Refractory or Relapsed Acute Myeloid Leukemia

By  

Oncology Research and Treatment, Vol. 27, Iss. 3, 2004-07 ,pp. : 269-272

Karger

Access to resources Recommend Favorite

Measles Giant-Cell Pneumonia in Two Children with Acute Myeloid Leukemia

By  

Oncology Research and Treatment, Vol. 23, Iss. 3, 2000-07 ,pp. : 262-264

Karger

Access to resources Recommend Favorite

Immunotherapy in acute myeloid leukemia

By  

CANCER, Vol. 121, Iss. 16, 2015-08 ,pp. : 2689-2704

John Wiley & Sons Inc

Access to resources Recommend Favorite